Profile for Oragenics Inc. (OGEN)

$ 0.7876   0.0203 (+2.65%) Volume: 4.93m 8:00 PM EDT 7-Jul-2020
After Hours:  $ 0.7758   -0.0118 (-1.50%) Volume: 45.18k 7:43 PM EDT 7-Jul-2020
Business Description:
Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.
Address: 4902 Eisenhower Boulevard, Suite 125, Tampa, FL, USA, 33634
Telephone: +1 813 286-7900 Website:
Facsimile: +1 813 286-7904 Email: [email protected]
CEO: Alan F. Joslyn
Employees: 7 Market Cap: 43.6m
Issue Type: CS
Auditor: Mayer Hoffman McCann P.C.
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1174940
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)